Skip to content

LMWH Compliance in Pregnancy

Compliance With Long-term Low-molecular-weight Heparin Prophylaxis/Treatment in the Anatenatal and Postnatal Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05066867
Enrollment
100
Registered
2021-10-04
Start date
2021-01-01
Completion date
2022-04-01
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antenatal Deep Vein Thrombosis, Venous Thromboembolism

Keywords

Pregnancy thromboprophylaxis, LMWH compliance

Brief summary

This is a prospective chart study that will aim to assess objective data on compliance levels to low molecular weight heparin (LMWH) injections among pregnant and postnatal women undergoing VTE thromboprophylaxis treatment at Cork University Maternity Hospital. This is a study that will help shine light on accurate data for compliance and possible factors affecting it, which will be useful for more individualised treatment plans for future patients. Patients at higher risk of Venous thromboembolism undergoing VTE thromboprophylaxis will be invited to participate in the study. Once the patient reads the information leaflet and signs consent, data will then be collected from the patients medical record. The patient will be given a smart sharps bin with an individual, unique product code. This device will be provided by HealthBeacon, a Dublin based start-up company. The device will be personalised with the treatment schedule pre-loaded onto it. When a used LMWH injection is disposed into the smart sharps bin, an infrared sensor is activated. The system captures an image of the injection in the chamber before moving it to the normal 'sharps' container of the bin for disposal. The captured image is time-stamped and sent to HealthBeacon's electronic database. HealthBeacon will only have the data pertaining to the disposal of injections for each sharps bin (i.e. the timing of the disposal of each used injection in each pre-coded bin). We are blinded to the compliance information and will only will receive the raw Data once treatment is completed. Data will be analysed to determine compliance of LMWH injections. This study will enable us to have a better insight on accurate compliance rates for LMWH injections in pregnant women at higher risk for venous thromboembolism (VTE). Understanding compliance with LMWH injections and the factors which can affect it, will hopefully guide future information and education that we offer to patients who are prescribed LMWH injections and help decrease maternal mortality rates in future.

Interventions

OTHERSmart sharps bin - collects data on compliance

collects compliance data

Sponsors

HealthBeacon ICMS
CollaboratorUNKNOWN
Cork University Maternity Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* current VTE * previous history of VTE * class III obesity * history of placenta mediated complications * pre-eclampsia * Advanced Maternal Age * inherited thrombophilia * prolonged immobilization * varicose veins * other risk factors that predispose them to VTE

Exclusion criteria

* life-long anti-coagulation * mechanical heart valves * other forms of injectable therapy for other illnesses * long-term severe physical disability affecting mobility (eg: paraplegia, paralysis

Design outcomes

Primary

MeasureTime frameDescription
LMWH compliance levels in pregnancy18 monthsCompliance is described as a patient taking at least 80% of LMWH injections

Secondary

MeasureTime frameDescription
Sociodemographic factors18 monthsTo determine sociodemographic factors that influence compliance

Countries

Ireland

Contacts

Primary ContactRebecca M Cole, M.B.
rebecca.cole@ucc.ie+353214920500
Backup ContactJohn RJ Higgins, M.D.
j.higgins@ucc.ie+353214920749

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026